HealthcareServices

Stem Cell Therapy For Infertility Market 2026–2030: Emerging Trends and Forecast Opportunities

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell therapy for infertility market from 2026–2035 with trusted insights from The Business Research Company

How is the Stem Cell Therapy For Infertility Market size predicted to change over the forecast window of 2026–2035?

The stem cell therapy for infertility market has experienced substantial growth in recent years. It is projected to expand from $1.87 billion in 2025 to $2.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.6%. This historical development can be attributed to factors such as the increasing prevalence of infertility conditions, the global proliferation of fertility clinics, advancements in reproductive biology research, a growing demand for alternative infertility treatments, and the expansion of assisted reproductive procedures.

The stem cell therapy for infertility market is projected for significant expansion over the coming years, reaching a valuation of $3.99 billion by 2030, driven by a compound annual growth rate (CAGR) of 16.4%. This expansion is primarily driven by factors such as the increasing clinical validation of stem cell infertility treatments, escalating investments in reproductive regenerative medicine, the growing acceptance of personalized fertility solutions, an expansion of clinical trials in reproductive health, and enhanced collaboration between fertility clinics and research institutions. Key trends anticipated during this period encompass a heightened focus on ovarian and testicular regeneration therapies, an increased adoption of autologous stem cell treatments, greater integration with assisted reproductive technologies, the expansion of personalized fertility treatment protocols, and intensified clinical research in reproductive regeneration.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

Which Drivers Are Contributing To The Expansion Of The Stem Cell Therapy For Infertility Market?

The increasing instances of infertility are projected to substantially contribute to the expansion of the stem cell therapy for infertility market moving forward. Infertility describes a couple’s inability to conceive after 12 months or more of regular unprotected sexual intercourse. The growing occurrence of infertility is largely due to individuals delaying childbearing, as many choose to have children later in life, leading to a reduction in fertility stemming from the natural decrease in reproductive potential with age, particularly among women. Stem cell therapy for infertility offers promising solutions by regenerating damaged reproductive tissues, enhancing ovarian and testicular function, and improving the chances of conception. For example, in April 2023, according to a report published by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, infertility affects approximately 17.5% of the adult population, or about 1 in 6 people globally, emphasizing the increasing necessity to broaden access to affordable and high-quality fertility care. Therefore, the rising cases of infertility are expected to fuel the growth of the stem cell therapy for infertility market.

What Segment Categories Are Covered In The Stem Cell Therapy For Infertility Market?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

What Trends Are Reshaping The Dynamics Of The Stem Cell Therapy For Infertility Market?

Leading companies in the stem cell therapy for infertility market are concentrating on advancements in stem cell technologies, such as induced pluripotent stem cells (iPSCs), to improve personalized regenerative treatments, enhance patient-specific outcomes, and expand the variety of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells genetically reprogrammed into an embryonic-like pluripotent state, allowing them to differentiate into almost any cell type in the body. For example, in January 2025, Gameto Inc., a US-based biotechnology company, launched a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This trial, involving approximately 15 sites across the U.S., aims to evaluate egg maturation outside the body with engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If successful, this would be the first late-stage clinical program for an in-vitro matured egg therapy derived from induced pluripotent stem cells for the treatment of infertility.

Which Leading Companies Dominate The Stem Cell Therapy For Infertility Market Share?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

How Does The Stem Cell Therapy For Infertility Market Perform Across Major Global Regions?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Stem Cell Therapy For Infertility Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30408&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Fertility Treatments Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795